公开(公告)号：US20240325478A1

公开(公告)日：2024-10-03

申请号：US18621062

申请日：2024-03-28

Applicant: Ningxia Medical University ,  Ningxia Freedom Biological Pharmaceutical Technology Co., LTD

Inventor： Rui He ,  Guangyong Li ,  Xiaojiang Chen ,  Xiaoli Du ,  Xiangdong Zhu ,  Huiming Ma ,  Miao Sun ,  Jiafuruzi He

IPC: A61K36/232 ,  A61K36/076 ,  A61K36/185 ,  A61K36/235 ,  A61K36/236 ,  A61K36/24 ,  A61K36/284 ,  A61K36/344 ,  A61K36/48 ,  A61K36/481 ,  A61K36/484 ,  A61K36/54 ,  A61K36/62 ,  A61K36/67 ,  A61K36/714 ,  A61K36/754 ,  A61K36/894 ,  A61K36/9062 ,  A61K36/9068 ,  A61P15/08

CPC classification number: A61K36/232 ,  A61K36/076 ,  A61K36/185 ,  A61K36/235 ,  A61K36/236 ,  A61K36/24 ,  A61K36/284 ,  A61K36/344 ,  A61K36/48 ,  A61K36/481 ,  A61K36/484 ,  A61K36/54 ,  A61K36/62 ,  A61K36/67 ,  A61K36/714 ,  A61K36/754 ,  A61K36/894 ,  A61K36/9062 ,  A61K36/9068 ,  A61P15/08 ,  A61K2236/331

Abstract: A traditional Chinese medicine compound for improving testicular dysfunction is made from the following raw materials: Codonopsis pilosula, Astragalus membranaceus, Dioscorea opposita, Angelica sinensis, Atractylodes macrocephala, Poria cocos, Cynanchum otophyllum, Psoralea corylifolia, Ligusticum chuanxiong, Nelumbo nucifera, Euryale ferox, Amomum villosum, Alpinia katsumadai, Foeniculum vulgare, Cinnamomum cassia, Evodia ruticarpa, Piper nigrum, Zingiber officinale, Aconitum carmichaelii, and Glycyrrhiza uralensis. All the raw materials are combined, so that the spleen, the stomach and the kidney are in harmony, the qi, the blood and the body fluid are recovered, and the kidney essence is active. Animal experiments show that the traditional Chinese medicine compound can up-regulate expressions of phosphatidylinositol 3-kinase (PI3K), phospho-protein kinase B (p-AKT) and B-cell lymphoma-2 (Bcl-2), improve testicular dysfunction, improve hormone secretion, regulate a male reproductive endocrine environment of the body, and further improve semen parameters.

公开(公告)号：US12090186B2

公开(公告)日：2024-09-17

申请号：US17222768

申请日：2021-04-05

Applicant: Moringo Organics Inc.

Inventor： Karen Vieira ,  John Britto

IPC: A61K36/00 ,  A61K9/00 ,  A61K9/48 ,  A61K31/4525 ,  A61K35/04 ,  A61K35/74 ,  A61K35/748 ,  A61K36/185 ,  A61K36/31 ,  A61K36/47 ,  A61K36/48 ,  A61K36/53 ,  A61K36/61 ,  A61K36/67 ,  A61K36/9066 ,  A61P3/06 ,  A61P3/10 ,  A61P39/06

CPC classification number: A61K36/31 ,  A61K9/0053 ,  A61K9/48 ,  A61K31/4525 ,  A61K35/04 ,  A61K35/74 ,  A61K35/748 ,  A61K36/185 ,  A61K36/47 ,  A61K36/48 ,  A61K36/53 ,  A61K36/61 ,  A61K36/67 ,  A61K36/9066 ,  A61P3/06 ,  A61P3/10 ,  A61P39/06 ,  A61K2300/00 ,  A61K2300/00 ,  A61K36/185 ,  A61K2300/00 ,  A61K36/47 ,  A61K2300/00 ,  A61K36/48 ,  A61K2300/00 ,  A61K36/53 ,  A61K2300/00 ,  A61K36/67 ,  A61K2300/00 ,  A61K36/9066 ,  A61K2300/00 ,  A61K35/74

Abstract: The main objective of the present invention is to develop an herbal formulation with high polyphenol concentrations. A therapeutic effect of ingredients in herbal composition with Antioxidants, Anti-inflammatories, Anti Viral & Anti Microbial properties to reduce Oxidative Stress, Inflammation, Viral and Microbial Infections. The herbal composition promotes management of diabetes, regulation of cholesterol, also immune system processes that helps to fight against viral and bacterial infections, colds, or the flu, skin ailments such as Psoriasis & eczema. Herbal Composition comprises synergistic combination of Moringa oleifera Leaf Powder, Spirulina & Aqueous extracts of Oregano vulgare Leaf Extract, Shilajit extract, Rosemary Leaf extract, Pomegranate Fruit Preel extract, Amla fruit extract, Fenugreek Seed Extract, Curcumin Extract, Piperine extract. Therefore, the chosen herbal blend provides the body with all of the vitamins, minerals, and nutrients it needs to continuously boost health.

公开(公告)号：US11986510B2

公开(公告)日：2024-05-21

申请号：US17369855

申请日：2021-07-07

Applicant: SL Technology, Inc.

Inventor： Alfredo Flores Galvez ,  Ryan Schmidt ,  Carl Hastings

IPC: A61K38/16 ,  A23L33/105 ,  A23L33/18 ,  A61K31/353 ,  A61K36/03 ,  A61K36/064 ,  A61K36/10 ,  A61K36/48 ,  A61K36/484 ,  A61K36/52 ,  A61K36/67 ,  A61K36/708 ,  A61K36/738 ,  A61K36/8962

CPC classification number: A61K38/168 ,  A23L33/105 ,  A23L33/18 ,  A61K31/353 ,  A61K36/03 ,  A61K36/064 ,  A61K36/10 ,  A61K36/48 ,  A61K36/484 ,  A61K36/52 ,  A61K36/67 ,  A61K36/708 ,  A61K36/738 ,  A61K36/8962 ,  A23V2002/00 ,  A61K36/064 ,  A61K2300/00 ,  A61K36/48 ,  A61K2300/00 ,  A61K36/03 ,  A61K2300/00 ,  A61K36/484 ,  A61K2300/00 ,  A61K36/708 ,  A61K2300/00 ,  A61K36/67 ,  A61K2300/00 ,  A61K36/738 ,  A61K2300/00 ,  A61K36/52 ,  A61K2300/00 ,  A61K36/10 ,  A61K2300/00 ,  A61K36/8962 ,  A61K2300/00

Abstract: This invention relates generally to products and methods using lunasin-enriched soy extract combined with Reliv Now® to reduce free fatty acid levels and increase leptin levels and adiponectin levels in plasma for the control of obesity, type 2 diabetes and metabolic syndrome. More specifically, the present invention relates to novel compositions comprising lunasin enriched soy extract and Reliv Now® formulations, methods of using these compositions in individuals for the control of obesity, type 2 diabetes and metabolic syndrome, and methods of making compositions comprising them.

公开(公告)号：US11951144B2

公开(公告)日：2024-04-09

申请号：US17268316

申请日：2018-09-12

Applicant: PM-INTERNATIONAL AG

Inventor： Rolf Sorg ,  Tobias Kühne ,  Christian Lauinger ,  Wilhelm Messer

IPC: A61K36/00 ,  A23L33/105 ,  A23L33/125 ,  A23L33/135 ,  A23L33/14 ,  A23L33/15 ,  A23L33/16 ,  A23L33/22 ,  A61K31/12 ,  A61K31/197 ,  A61K31/355 ,  A61K31/375 ,  A61K31/4188 ,  A61K31/4415 ,  A61K31/455 ,  A61K31/51 ,  A61K31/519 ,  A61K31/522 ,  A61K31/525 ,  A61K31/593 ,  A61K31/714 ,  A61K33/06 ,  A61K33/30 ,  A61K33/34 ,  A61K35/20 ,  A61K36/064 ,  A61K36/67 ,  A61K36/9068 ,  A61K47/12 ,  A61K47/26 ,  A61K47/36 ,  A61K47/46 ,  A61K47/69

CPC classification number: A61K36/67 ,  A23L33/105 ,  A23L33/125 ,  A23L33/135 ,  A23L33/14 ,  A23L33/15 ,  A23L33/16 ,  A23L33/22 ,  A61K31/12 ,  A61K31/197 ,  A61K31/355 ,  A61K31/375 ,  A61K31/4188 ,  A61K31/4415 ,  A61K31/455 ,  A61K31/51 ,  A61K31/519 ,  A61K31/522 ,  A61K31/525 ,  A61K31/593 ,  A61K31/714 ,  A61K33/06 ,  A61K33/30 ,  A61K33/34 ,  A61K35/20 ,  A61K36/064 ,  A61K36/9068 ,  A61K47/12 ,  A61K47/26 ,  A61K47/36 ,  A61K47/46 ,  A61K47/6951 ,  A23V2002/00 ,  A23V2400/113 ,  A23V2400/173

Abstract: A composition, containing



a pepper component,
a curcumin-cyclodextrin mixture and
a mixture of fruits, vegetables and spices.

公开(公告)号：US20240091295A1

公开(公告)日：2024-03-21

申请号：US18226218

申请日：2023-07-25

Applicant: Kodimule Shyam PRASAD ,  Kuluvar Gouthamchandra ,  Karempudi Venkatakrishna ,  Kuppam Sundeep ,  Heggar Sudeep

Inventor： Kodimule Shyam PRASAD ,  Kuluvar Gouthamchandra ,  Karempudi Venkatakrishna ,  Kuppam Sundeep ,  Heggar Sudeep

IPC: A61K36/67 ,  A61K31/015 ,  A61P29/00

CPC classification number: A61K36/67 ,  A61K31/015 ,  A61P29/00

Abstract: The invention provides a composition comprising an extract of black pepper seeds having β-caryophyllene as a bioactive ingredient. The invention also provides a method of providing pain relief, comprising administering to a subject in need thereof an effective amount of the inventive composition.

公开(公告)号：US20240082364A1

公开(公告)日：2024-03-14

申请号：US18463879

申请日：2023-09-08

Applicant: doTERRA Holdings, LLC

Inventor： Alex McGregor DaBell ,  Nicole Stevens

IPC: A61K38/39 ,  A61K8/65 ,  A61K8/9789 ,  A61K8/9794 ,  A61K31/05 ,  A61K31/132 ,  A61K31/164 ,  A61K31/205 ,  A61K31/23 ,  A61K31/375 ,  A61K31/4188 ,  A61K31/4375 ,  A61K31/706 ,  A61K31/7084 ,  A61K31/728 ,  A61K33/06 ,  A61K35/60 ,  A61K36/185 ,  A61K36/258 ,  A61K36/31 ,  A61K36/48 ,  A61K36/53 ,  A61K36/534 ,  A61K36/605 ,  A61K36/61 ,  A61K36/67 ,  A61Q19/00

CPC classification number: A61K38/39 ,  A61K8/65 ,  A61K8/9789 ,  A61K8/9794 ,  A61K31/05 ,  A61K31/132 ,  A61K31/164 ,  A61K31/205 ,  A61K31/23 ,  A61K31/375 ,  A61K31/4188 ,  A61K31/4375 ,  A61K31/706 ,  A61K31/7084 ,  A61K31/728 ,  A61K33/06 ,  A61K35/60 ,  A61K36/185 ,  A61K36/258 ,  A61K36/31 ,  A61K36/48 ,  A61K36/53 ,  A61K36/534 ,  A61K36/605 ,  A61K36/61 ,  A61K36/67 ,  A61Q19/00 ,  A61K2236/331 ,  A61K2236/333 ,  A61K2236/37 ,  A61K2236/51

Abstract: Compositions may include at least one whole or partial CPTG essential oil component, at least one marine or other collagen type component including greater than 70% tripeptides, and at least one whole or partial constituent component. Methods for preparing essential oil food product formulations for animal or human consumption may involve mixing at least one whole or partial CPTG essential oil component, at least one marine or other collagen type component comprising greater than 70% tripeptides, at least one whole or partial constituent component, and a liquid until at least substantially homogenous. Other compositions may include at least one essential oil component and at least one marine or other collagen type component. A ratio by weight of the at least one essential oil component to the at least one marine or other collagen type component may be within a range of from about 2:0 to about 10:1.

公开(公告)号：US11839636B1

公开(公告)日：2023-12-12

申请号：US17815548

申请日：2022-07-27

Applicant: Babry Oren ,  Sasha Moshe

Inventor： Babry Oren ,  Sasha Moshe

IPC: A61K36/15 ,  A61K36/87 ,  A61K36/906 ,  A61K9/00 ,  A61K36/31 ,  A61K36/67 ,  A61K36/82

CPC classification number: A61K36/15 ,  A61K9/0056 ,  A61K36/31 ,  A61K36/67 ,  A61K36/82 ,  A61K36/87 ,  A61K36/906

Abstract: A pharmaceutical composition containing dry powder of pine (Pinus) needles and dry peels and pits of grapes extract and pharmaceutically acceptable additive, dry extracts of ginger (Zingiber officinale), green tea (Camellia sinensis), yellow ginger (Curcuma longa), yellow mustard (Brassica hirta) seeds, white pepper, pomegranate (Punica granatum) bark and dry powder of pomegranate (Punica granatum) juice.

公开(公告)号：US20230346868A1

公开(公告)日：2023-11-02

申请号：US18213022

申请日：2023-06-22

Applicant: Botanic Tonics, LLC

Inventor： Jerry Wayne Ross

IPC: A61K36/67 ,  A61K31/366 ,  A61K9/16 ,  A61K31/4375 ,  A61K41/17 ,  A61K36/74

CPC classification number: A61K36/67 ,  A61K31/366 ,  A61K9/1688 ,  A61K31/4375 ,  A61K41/17 ,  A61K36/74 ,  A61K2236/17 ,  A61K2236/15 ,  A61K2236/53

Abstract: Kava and kratom compositions are described herein along with the methods of producing the same. The description contained herein describes methods for making a purified kava composition that is free or substantially free of flavokavain A and flavokavain B. In some embodiments, the kava composition is formulated as a ready-to-drink beverage. Certain compositions comprise a combination of a kava composition and a kratom composition made in accordance with the methods described herein.

公开(公告)号：US11793852B2

公开(公告)日：2023-10-24

申请号：US17079524

申请日：2020-10-26

Applicant: Shanghai Zhonghua Pharmaceutical Co., Ltd

Inventor： Jiahua Jin ,  Biye Wang ,  Liqin Ding ,  Wujie Cao ,  Xiaoping Zhu ,  Tian Lan

IPC: A61K36/9068 ,  A61P1/16 ,  A61K31/045 ,  A61K36/28 ,  A61K36/484 ,  A61K36/534 ,  A61K36/54 ,  A61K36/61 ,  A61K36/67 ,  A61K36/79 ,  A61K36/899 ,  A61K36/9064 ,  A61K47/02 ,  A61K47/12 ,  A61K47/34 ,  A61K47/36 ,  A61K36/285 ,  A61K36/48 ,  A61K36/57

CPC classification number: A61K36/9068 ,  A61K31/045 ,  A61K36/28 ,  A61K36/285 ,  A61K36/48 ,  A61K36/484 ,  A61K36/534 ,  A61K36/54 ,  A61K36/57 ,  A61K36/61 ,  A61K36/67 ,  A61K36/79 ,  A61K36/899 ,  A61K36/9064 ,  A61K47/02 ,  A61K47/12 ,  A61K47/34 ,  A61K47/36 ,  A61P1/16

Abstract: An application of Longhu Rendan in preparing a medicament for preventing and/or treating liver fibrosis. The Longhu Rendan has significant effect in improving fibrosis, and its effect in anti-liver fibrosis and liver protection is equivalent to those of a positive drug silybin.

公开(公告)号：US11723941B2

公开(公告)日：2023-08-15

申请号：US17013260

申请日：2020-09-04

Applicant: Amare Global

Inventor： Shawn M. Talbott

IPC: A61K36/73 ,  A61K36/63 ,  A61K36/324 ,  A23L33/00 ,  A61K36/67 ,  A23L33/105 ,  A61K36/23

CPC classification number: A61K36/73 ,  A23L33/105 ,  A23L33/30 ,  A61K36/23 ,  A61K36/324 ,  A61K36/63 ,  A61K36/67

Abstract: Nutritional supplements and methods of nutritional supplementation affecting the endocannabinoid system are provided. These nutritional supplements and methods of nutritional supplementation support the endocannabinoid systems of subjects by providing a blend of hemp oil, black pepper oil, black cumin seed oil, and white frankincense oil to prime ECS receptors and activate them to provide improvements to the ECS in a subject, affecting their pain response, mood, stress response, and sleep.